2023 Early Hearing Detection & Intervention Conference
March 5-7, 2023 • Cincinnati, OH
DUKE ENERGY CONVENTION CENTER
The Importance of CMV Screening
Human Cytomegalovirus (CMV) is a ubiquitous human-specific DNA virus, belonging to the Herpesviridae family (Marsico & Kimberlin, 2017). It distinguishes itself as the leading global nongenetic cause of sensorineural hearing loss (SNHL) and a major instigator of neurodevelopmental disabilities in children. It is a global health crisis affecting 0.3-1.7% of all newborns (McCrary et al., 2018) and proves most severe in its congenital form (cCMV). Despite its clinical significance, cCMV is often undetected because most infected infants do not exhibit symptoms at birth and screening programs are not implemented nationwide (Fowler & Boppana, 2018). As states and countries, debate the need for policies for cCMV screening with eight states providing legislation that require screening of each newborn that fails the newborn hearing screening and stakeholders posing laws in other states, we hope to create a white paper that educates laypeople and health care workers on the importance of cCMV screening and how to effectively perform it. An analysis of all recent and historical research of cCMV was performed and noted everything we know and have yet to know about this virus and its impacts. While further analyses, reviews, and edits are still to be made before the publication of this white paper; preliminary findings show the wide scope of impact of cCMV and emphasize the need for screening. In addition to these findings, this presentation will display the current initiatives being implemented nationwide and how exactly CMV screening is performed to better inform health professionals on the necessity for screening and the urgency to do so in the face of various prognoses and manifestations of this virus in our population.
- Participant will be able to identify three possible long-term effects of CMV
- Participant will be able to recognize and assess the global prevalence and incidence of CMV
- Participant will be able to list three reasons to support congenital CMV screening
Poster:
3420032_15510AnaSale.pdf
Presenter: Robert Fifer
Robert C. Fifer, is the Director of Audiology and Speech-Language Pathology at the Mailman Center for Child Development, University of Miami School of Medicine. He received his B.S. from the University of Nebraska in Speech-Language Pathology with a minor in Deaf Education. His M.A. is from Central Michigan University in Audiology, and his Ph.D. is from Baylor College of Medicine in Audiology and Bioacoustics. Dr. Fifer’s clinical and research interests include auditory evoked potentials, central auditory processing, early detection of hearing loss in children, and auditory anatomy and physiology. He is a Past-President of the Florida Association of Speech-Language Pathologists and Audiologists, a member of ASHA’s Health Care Economics Committee, and the ASHA representative to the American Medical Association’s Health Care Professions Advisory Committee for the Relative Value Utilization Committee in addition to being ASHA’s representative to the AMA’s Practice Expense Advisory Committee.
ASHA DISCLOSURE:
Financial -
• Receives Salary for Employment from University of Miami.
Nonfinancial -
No relevant nonfinancial relationship exist.
Ana Carolina Gahyva Sale BS, BA, “MD”, “MPH” PERSONAL STATEMENT/GOALS: Ana Carolina Sale is a dual degree medicine and public health student (MD/MPH) at the University of Miami Miller School of Medicine with an educational background in human rights (BA), health and society (BS) and biology (BS) with over 4 years of domestic and international service, education, and research experience in public health. Her program of research aims to assess health systems and ways that they could improve as well as the effects of poor public health implementation on the health and well-being of populations. She focuses on finding ways to improve health access and education in ways that decrease comorbidities among families and children. She is especially concerned about redressing disparities in infectious disease and nutrition and their effects on cognitive and physical development. ACADEMIC BACKGROUND: Ana Carolina Gahyva Sale earned her Bachelor of Science degrees in Biology and Health and Society, with distinction, along with a Bachelor of Art in Human Rights from Southern Methodist University in 2020. In 2021, she began her pursuit of a dual degree in medicine and public health (MD/MPH) at the University of Miami Miller School of Medicine. During her undergraduate studies, she completed international studies in human rights and history in Spain and Israel along with studies on health, community, and policy in South Africa, India, and Brazil through the School of International Training (SIT). AREAS OF RESEARCH INTEREST: Moral Distress, Neurodevelopmental Disorders, Disease Prevention, Infectious Disease, Maternal and Child Health, Global Health RESEARCH EXPERIENCE: Ana Carolina Sale is a current medical and public health student who led an ethnographic, mixed methods study on moral distress among health care workers and caretakers at an NGO in Rio de Janeiro, Brazil in 2019 with a manuscript expected to be published 03/2022. With this research, she has presented and been recognized as an Engaged Learning Fellow, Maguire Public Service Fellow, Richter International Fellow, and Hamilton Undergraduate Research Scholar. She has also had experience conducting biochemical research on BLR1 and the LOV domain as well as performing case studies on environmental and socioeconomic impacts on health.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Evelyn Roberto, MSN, APRN, FNP-BC graduated from Keiser University with her Associate of Science in Nursing (ASN) in 2010. She later completed her Bachelor of Science in Nursing (BSN) in 2012 at Florida International University (FIU) with consecutive Dean’s Honor Roll-distinction. After working for several years in the Neonatal Intensive Care Unit (NICU) of Nicklaus Children’s Hospital (formerly known as Miami Children’s Hospital), she obtained her Master of Science in Nursing (MSN) with focus on family medicine in 2017 from Keiser University and achieved her certification as a Family Nurse Practitioner (FNP-BC) from the American Nurses Credentialing Center (ANCC) afterwards. Evelyn has a diverse working background, consisting of primary and urgent care settings and has been awarded the Florence Nightingale Award for Nursing Excellence. She has also been a member of the National Association of Neonatal Nurses (NANN) and her local Florida Chapter, South Eastern Florida Association of Neonatal Nurses (SEFANN). She is currently pursuing her Doctorate of Nursing Practice (DNP) at the University of Miami that has inspired her interest in the infant acquisition of congenital cytomegalovirus and its implications.
ASHA DISCLOSURE:
Financial -
Nonfinancial -